Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2383 (LINC02383) is a member of the long intergenic non-coding RNA (lincRNA) family. LincRNAs are typically defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap with annotated protein-coding genes[3][7]. These molecules are involved in diverse biological processes including regulation of gene expression, chromatin remodeling, RNA stabilization, and transcriptional regulation—often exhibiting remarkable tissue specificity[3][5][7]. While lincRNAs are increasingly recognized to have important cellular roles, the specific biological functions and disease associations of LINC02383 have not been characterized in detail as of the most current available annotations[1]. There is currently no evidence that LINC02383 is a direct therapeutic target, interacts with any drugs, or serves as a clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2383 (LINC02383).